Response to letter entitled: Tixagevimab/cilgavimab pre-exposure prophylaxis and breakthrough infection risk in vaccinated solid organ transplant recipients: Concern for immortal time bias effect.

Al Jurdi, Ayman; Morena, Leela; Riella, Leonardo V

Al Jurdi, Ayman; Morena, Leela; Riella, Leonardo V.

Al Jurdi A; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Maryland, USA; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Maryland, USA; Harvard Medical School, Boston, Massachusetts, USA.
Morena L; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Maryland, USA; Harvard Medical School, Boston, Massachusetts, USA.
Riella LV; Center for Transplantation Sciences, Massachusetts General Hospital, Boston, Maryland, USA; Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, Maryland, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: lriella@mgh.harvard.edu.

Am J Transplant ; 23(3): 451-452, 2023 03.

Article in English | MEDLINE | ID: covidwho-2289297

Subject(s)

Organ Transplantation; Pre-Exposure Prophylaxis; Humans; Breakthrough Infections

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organ Transplantation / Pre-Exposure Prophylaxis Type of study: Experimental Studies / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Am J Transplant Journal subject: Transplantation Year: 2023 Document Type: Article Affiliation country: J.ajt.2023.01.009

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google